battle of glp 1 delivery technologies What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care battle of glp-1 delivery technologies

The search strategy combined the Medical Subject Heading (MeSH) terms exenatide OR liraglutide OR semaglutide OR dulaglutide OR albiglutide OR lixizenatide AND diabetes mellitus, type 2 AND a filter to identify RCTs 14

Most studies have been short-term (812 weeks), involved small sample sizes, and used heterogeneous probiotic formulations, making it difficult to draw definitive conclusions about efficacy or to identify which specific strains might be beneficial

Early recommendations often advised stopping the medications before surgery

N Engl J Med 391: 11931205

They mimic the effects of the natural hormone (GLP-1) that regulates appetite, digestion and blood sugar levels